SGMO logo
SGMO

Sangamo Therapeutics Inc

Biotechnology

Sangamo Therapeutics Inc (SGMO) Earnings

Last reported
May 18, 2026
EPS estimate
$0.01
EPS actual
Revenue est.
$34.4M
Revenue actual